NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
29/06/2023
Voltar para busca
Dado oficial do USPTO
QIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
29/06/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 42
Data de depósito
10/02/1999
Data de registro
31/12/2002
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/06/2023
Última transação
29/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
1
Tipo de titular
03
Localização do titular
Hilden, DE
Examinador
LEVINE, HOWARD B
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Qiagen GmbH
Qiagen GmbH
Representantes
Victoria Friedman Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical preparations for manufacturing use in chemicalpharmaceutical and biotechnology industries and for scientific laboratory usereagents for altering the molecular structure of polymers; biological agents for laboratories for scientific and research use; chromatographic material for carrying out chromatographic separationpurification and/or isolation methods of biopolymerschemicals for use in the separationpurification and isolation of biopolymersreagents and solvents; chromatographic chemicals contained in cartridges and columns for use in the separationpurification and isolation of biopolymers; chromatographic chemicalsreagentssolvent type processing compositions packaged in sets of columns or cartridges for the separationpurification and/or isolation of biopolymers; chromatographic chemical materialloose or packed in cartridgesfor use in the preparation of nucleic acids; kits for the preparation of nucleic acids consisting primarily of chemicals in the nature of buffers contained in flasksfilterscolumnsbottlesreaction tubes and receptacles for scientific and research laboratory use; research kits consisting primarily of chemical reagents contained in tubes for use in the measurement of polymer chain-reactions; chemicals for scientific and industrial laboratory research usechromatographic chemicals contained in spin columns for use in microcentrifuges; biological agents for use in the manufacture of pharmaceuticals; diagnostic agents for scientific and/or research use in the pharmaceuticalmedical and veterinary fields; scientific and/or research diagnostic agents for use in laboratory assays for human and veterinary medical and phytopathological use; kits for the preparation of nucleic acids consisting primarily of chemicals in the nature of buffers and lipids contained in flasksfilterscolumnsbottlesreaction tubes and receptacles for scientific and research laboratory use; chemical preparations for introducing molecules and molecule aggregates into prokaryotic and eukaryotic cellspeptides and/or nucleic acids; kits consisting primarily of peptides and/or nucleic acids for introducing molecules and molecule aggregates into prokaryotic and eukaryotic cells; chemical preparation for scientific usetransfection reagents for the isolation and purification of nucleic acids
Classe 5
medical and veterinary diagnostic agents for clinical laboratory use; clinical diagnostic agents for use in laboratory assays for human and veterinary medical use; diagnostic agents for the chromatographic analysis and preparation of nucleic acids for clinical medical use
Classe 9
kits for the preparation of nucleic acids consisting primarily of laboratory apparatus in the nature of flasksfilterscolumnsbottlesreaction tubes and receptaclesall containing chemical buffers; adaptorsconnectors and closures for chromatographic columns; mountings and receptacles for chromatographic spin columns; pipettesbottlescollection tubescollection receptacles; synthetic filtering membranes; scientific laboratory apparatus and instrumentsrobotsovenscentrifugeschromatographic columns; scientific laboratory devices for industry and research useflasksfilterschromatographic columnsbottlesreaction tubes; data processorscomputers; factory automation softwaresoftware to integrate fluid handling operations with manufacturing machine operations; and industrial process control software ; kits for the preparation of nucleic acids consisting primarily of laboratory apparatus in the nature of flasksfilterscolumnsbottlesreaction tubes and receptaclesall containing chemical buffers and lipids; pipettesbottlescollection tubescollection receptacles; laboratory filters used in the field of isolating cell ingredientssuch as nucleic acids from natural sources
Classe 42
services in the fields of biologicalbiomedicalbiotechnological research and development as well as molecular diagnostics and molecular medicinein particularresearch and development for third partiesisolation and purification of nucleic acids (biopolymers in general) for third partiessequencing and evaluating of the obtained data for third partiesdevelopment and application of computer programs used for the isolation and purification of biopolymers
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
29/06/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
29/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/06/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
02/12/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
31/12/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/01/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/01/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/01/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
20/12/2012
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/08/2009
PLGL
ASSIGNED TO PARALEGAL
06/07/2009
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
30/06/2009
E815
TEAS SECTION 8 & 15 RECEIVED
30/06/2009
CFIT
CASE FILE IN TICRS
07/03/2008
CORV
REVIEW OF CORRESPONDENCE COMPLETE
09/09/2006
PAPER RECEIVED
21/08/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2002
PUBO
PUBLISHED FOR OPPOSITION
08/10/2002
NPUB
NOTICE OF PUBLICATION
18/09/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/06/2002
PAPER RECEIVED
03/06/2002
CNSL
LETTER OF SUSPENSION MAILED
02/05/2002
DOCK
ASSIGNED TO EXAMINER
25/04/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2002
1.BD
Sec. 1(B) CLAIM DELETED
19/03/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/03/2002
PAPER RECEIVED
19/03/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2001
CNRT
NON-FINAL ACTION MAILED
28/07/1999
DOCK
ASSIGNED TO EXAMINER
19/07/1999
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.